retatrutide type 2 diabetes phase 2 trial hba1c π©Ί in diabetes: TRANSCEND-T2D-1 3 results β β2.0% + weight β16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. ππ Ref: Lilly Retatrutide is investigational and is
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5


























